Cytosorbents (CTSO) Earnings Date, Estimates & Call Transcripts → The #1 Crypto for 2024 (From InvestorPlace) (Ad) Free ctso Stock Alerts $0.80 +0.01 (+1.26%) (As of 04/18/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 7EstimatedActual EPS (Mar. 14) -$0.12 Beat By $0.02 Consensus EPS (Mar. 14) -$0.14 Get Cytosorbents Earnings AlertsEnter your email address below to receive the latest news and earnings results for CTSO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCTSO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CTSO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Weiss RatingsThe only accurate crypto trading system I know …Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. Cytosorbents Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243($0.13)($0.10)($0.11) Q2 20243($0.10)($0.07)($0.09) Q3 20243($0.08)($0.07)($0.08) Q4 20243($0.07)($0.06)($0.06) FY 202412($0.38)($0.30) ($0.34)CTSO Earnings Date and InformationCytosorbents last issued its earnings data on March 14th, 2024. The medical research company reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.14) by $0.02. The business had revenue of $8.67 million for the quarter, compared to analyst estimates of $9.29 million. Cytosorbents has generated ($0.64) earnings per share over the last year (($0.64) diluted earnings per share). Earnings for Cytosorbents are expected to grow in the coming year, from ($0.36) to ($0.17) per share. Cytosorbents has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off prior year's report dates.Read More Cytosorbents Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/7/2024Estimated)------- 3/14/2024Q4 2023($0.14)($0.12)+$0.02($0.12)$9.29 million$8.67 million11/9/2023Q3 2023($0.12)($0.21)($0.09)($0.21)$9.49 million$8.81 million8/1/2023Q2 2023($0.11)($0.14)($0.03)($0.14)$11.03 million$9.42 million5/2/2023Q1 2023($0.13)($0.17)($0.04)($0.17)$8.73 million$9.45 million3/9/2023Q4 2022($0.17)($0.01)+$0.16($0.01)$9.40 million$9.39 million11/3/2022Q3 2022($0.16)($0.28)($0.12)($0.28)$8.99 million$8.11 million Get the Latest News and Ratings for CTSO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cytosorbents and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Q2 2022($0.14)($0.25)($0.11)($0.25)$9.56 million$8.50 million5/3/2022Q1 2022($0.15)($0.21)($0.06)($0.21)$9.72 million$8.69 million 3/8/2022Q4 2021($0.13)($0.21)($0.08)($0.21)$9.72 million$10.78 million 11/4/2021Q3 2021($0.12)($0.15)($0.03)($0.15)$9.96 million$9.76 million 8/3/2021Q2 2021($0.03)($0.11)($0.08)($0.11)$12.29 million$12.02 million 5/4/2021Q1 2021($0.03)($0.10)($0.07)($0.10)$11.40 million$10.60 million Cytosorbents Earnings - Frequently Asked Questions When is Cytosorbents's earnings date? Cytosorbents has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 7th, 2024 based off last year's report dates. Learn more on CTSO's earnings history. Did Cytosorbents beat their earnings estimates last quarter? In the previous quarter, Cytosorbents (NASDAQ:CTSO) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.14) by $0.02. Learn more on analysts' earnings estimate vs. CTSO's actual earnings. How much revenue does Cytosorbents generate each year? Cytosorbents (NASDAQ:CTSO) has a recorded annual revenue of $36.35 million. How much profit does Cytosorbents generate each year? Cytosorbents (NASDAQ:CTSO) has a recorded net income of -$28.51 million. CTSO has generated -$0.64 earnings per share over the last four quarters. What is Cytosorbents's EPS forecast for next year? Cytosorbents's earnings are expected to grow from ($0.36) per share to ($0.17) per share in the next year. More Earnings Resources from MarketBeat Related Companies: NSPR Earnings Date APYX Earnings Date SRTS Earnings Date CTCX Earnings Date ICCM Earnings Date LUCD Earnings Date XAIR Earnings Date PDEX Earnings Date CODX Earnings Date DRIO Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff? This page (NASDAQ:CTSO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & CompanyTop 5 Tech Stocks to Buy for 2024Daily Market AlertsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytosorbents Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.